Buscar

Mostrando ítems 1-10 de 34

Maternal transfer of anti HPV 6 and 11 antibodies upon immunization with the 9-valent HPV vaccine

Guevara, Ana María; Suárez Pacheco, Eugenio; Victoria, Alejandro; Ngan, Hextan Y.S.; Hirschberg, Angélica Lindén; Fedrizzi, Edison; Bautista, Oliver; Shields, Christine; Joshi, Amita; Luxembourg, Alain (Taylor and Francis, 2019)

Background: This exploratory analysis was conducted to characterize the level of HPV types 6/11 antibodies in peripartum maternal blood and in cord blood of infants born to women who received 9-valent HPV (9vHPV) vaccine ...

Safety profile of the 9-valent human papillomavirus vaccine: assessment in prior quadrivalent HPV vaccine recipients and in men 16 to 26 years of age

Moreira Junior, Edson Duarte; Giuliano, A R; Hoon, J de; Iversen, O-E; Joura, E A; Restrepo, J; Van Damme, P; Vandermeulen, C; Ellison, M C; Krick, A; Shields, C; Heiles, B; Luxembourg, Alain (Taylor & Francis, 2018)

Immunogenicity and safety of the AS04-HPV-16/18 and HPV-6/11/16/18 human papillomavirus vaccines in asymptomatic young women living with HIV aged 15-25 years: A phase IV randomized comparative study

Folschweiller, Nicolas; Teixeira, Julio; Joshi, Smita; Goldani, Luciano Z.; Supparatpinyo, Khuanchai; Basu, Partha; Chotpitayasunondh, Tawee; Chetchotisakd, Ploenchan; Ruxrungtham, Kiat; Roteli-Martins, Cecilia; Grinsztejn, Beatriz; Quintana, Silvana Maria; Kumarasamy, Nagalingeswaran; Poongulali, Selvamuthu; Kulkarni, Vinay; Lin, Lan; Datta, Sanjoy K.; Descamps, Dominique; Dodet, Monique; Dubin, Gary; Friel, Damien; Hezareh, Marjan; Karkada, Naveen; Meric Camilleri, Dorothee; Poncelet, Sylviane; Salaun, Bruno; Tavares-da-Silva, Fernanda; Thomas-Jooris, Florence; Struyf, Frank (Elsevier, 2020)

Safety Profile of the 9-Valent HPV Vaccine: A Combined Analysis of 7 Phase III Clinical Trials

Moreira Júnior, Edson Duarte; Block, Stan L; Ferris, Daron; Giuliano, Anna R; Iversen, Ole-Erik; Joura, Elmar A; Kosalaraksa, Pope; Schilling, Andrea; Van Damme, Pierre; Bornstein, Jacob; Bosch, F Xavier; Pils, Sophie; Cuzick, Jack; Garland, Suzanne M; Huh, Warner; Kjaer, Susanne K; Qi, Hong; Hyatt, Donna; Martin, Jason; Moeller, Erin; Ritter, Michael; Baudin, Martine; Luxembourg, Alain (American Academy of Pediatrics, 2017)

Antibody persistence and evidence of immune memory at 5years following administration of the 9-valent HPV vaccine

Guevara, Ana; Cabello, Robinson; Woelber, Linn; Moreira Junior, Edson Duarte; Joura, Elmar; Reich, Olaf; Shields, Christine; Ellison, Misoo C; Joshi, Amita; Luxembourg, Alain (Elsevier, 2018)

Efficacy, immunogenicity, and safety of a 9-valent human papillomavirus vaccine in latin american girls, boys, and young women

Ruiz Sternberg, Angela María; Moreira, Edson D.; Restrepo, Jaime A.; Lazcano Ponce, Eduardo; Cabello, Robinson; Silva, Arnaldo; Andrade, Rosires; Revollo, Francisco; Uscanga, Santos; Victoria, Alejandro; Guevara, Ana María; Luna, Joaquín; Plata, Manuel; Nossa Dominguez, Claudia; Fedrizzi, Edison; Suárez, Eugenio; Reina, Julio C.; Ellison, Misoo C.; Moeller, Erin; Ritter, Michael; Shields, Christine; Cashat, Miguel; Perez, Gonzalo; Luxembourg, Alain (Elsevier, 2018-06)

Background: A 9-valent human papillomavirus (HPV6/11/16/18/31/33/45/52/58; 9vHPV) vaccine was developed to expand coverage of the previously developed quadrivalent (HPV6/11/16/18; qHPV) vaccine. Methods: Efficacy, ...

Safety Profile of the 9-Valent HPV Vaccine: A Combined Analysis of 7 Phase III Clinical Trials

A 9-valent HPV vaccine against infection and intraepithelial neoplasia in women

Joura, E. A.; Giuliano, Anna R.; Iversen, O. E.; Bouchard, C.; Mao, C.; Mehlsen, J.; Moreira Júnior, Edson Duarte; Ngan, Y.; Petersen, L. K.; Lazcano‑Ponce, E.; Pitisuttithum, P.; Restrepo, J. A.; Stuart, G.; Woelber, L.; Yang, Y. C.; Cuzick, J.; Garland, S. M.; Huh, W.; Kjaer, S. K.; Bautista, Oliver M.; Chan, I. S. F.; Chen, J.; Gesser, R.; Moeller, E.; Ritter, M.; Vuocolo, S.; Luxembourg, A.; Broad Spectrum HPV Vaccine Study (Massachusetts Medical Society, 2016)

Coadministration of a 9-Valent Human Papillomavirus Vaccine With Meningococcal and Tdap Vaccines

Schilling, Andrea; Macias Parra, Mercedes; Gutierrez, Maricruz; Restrepo, Jaime; Ucros, Santiago; Herrera, Teobaldo; Engel, Eli; Huicho, Luis; Shew, Marcia; Maansson, Roger; Caldwell, Nicole; Luxembourg, Alain; Sobanjo ter Meulen, Ajoke (Elsevier, 2001)

BACKGROUND: This study in 11- to 15-year-old boys and girls compared the immunogenicity and abstract safety of GARDASIL 9 (9-valent human papillomavirus [9vHPV] vaccine) administered either concomitantly or nonconcomitantly ...

Buscar

Filtros

Maternal transfer of anti HPV 6 and 11 antibodies upon immunization with the 9-valent HPV vaccine

Safety profile of the 9-valent human papillomavirus vaccine: assessment in prior quadrivalent HPV vaccine recipients and in men 16 to 26 years of age

Immunogenicity and safety of the AS04-HPV-16/18 and HPV-6/11/16/18 human papillomavirus vaccines in asymptomatic young women living with HIV aged 15-25 years: A phase IV randomized comparative study

Safety Profile of the 9-Valent HPV Vaccine: A Combined Analysis of 7 Phase III Clinical Trials

Antibody persistence and evidence of immune memory at 5years following administration of the 9-valent HPV vaccine

Efficacy, immunogenicity, and safety of a 9-valent human papillomavirus vaccine in latin american girls, boys, and young women

Safety Profile of the 9-Valent HPV Vaccine: A Combined Analysis of 7 Phase III Clinical Trials

A 9-valent HPV vaccine against infection and intraepithelial neoplasia in women

Coadministration of a 9-Valent Human Papillomavirus Vaccine With Meningococcal and Tdap Vaccines

Coadministration of a 9-Valent Human Papillomavirus Vaccine With Meningococcal and Tdap Vaccines